Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression
- 30 November 2007
- journal article
- Published by Elsevier in Human Pathology
- Vol. 38 (11) , 1628-1638
- https://doi.org/10.1016/j.humpath.2007.03.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancerSteroids, 2006
- Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivoBreast Cancer Research and Treatment, 2006
- Combined Surgical and Molecular TherapyAnnals of Surgery, 2006
- Chromosome 6p amplification and cancer progressionJournal of Clinical Pathology, 2006
- Progress in detection and treatment of prostate cancerCurrent Opinion in HIV and AIDS, 2005
- Andropause: Is Androgen Replacement Therapy Indicated for the Aging Male?Annual Review of Medicine, 2005
- Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and TumorsPublished by Elsevier ,2004
- Medical Management of Breast Cancer: Today and TomorrowCancer Biotherapy & Radiopharmaceuticals, 2002
- When Ets transcription factors meet their partnersBioEssays, 2002
- Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?Climacteric, 2002